Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Gene expression of estrogen receptor-alpha in orbital fibroblasts in Graves' ophthalmopathy

Full text
Author(s):
Cury, Sarah Santiloni [1] ; Oliveira, Miriane [1] ; Sibio, Maria Teresa [1] ; Clara, Sueli [1] ; Melo Luvizotto, Renata De Azevedo [1] ; Conde, Sandro [1] ; Jorge, Edson Nacib [2] ; Nunes, Vania dos Santos [1] ; Nogueira, Celia Regina [1] ; Ferreira da Silva Mazeto, Glaucia Maria [1]
Total Authors: 10
Affiliation:
[1] Sao Paulo State Univ Unesp, Botucatu Med Sch, Div Endocrinol, Dept Internal Med, Botucatu, SP - Brazil
[2] UNESP, Botucatu, SP - Brazil
Total Affiliations: 2
Document type: Journal article
Source: Arquivos Brasileiros de Endocrinologia e Metabologia; v. 59, n. 3, p. 273-276, JUN 2015.
Web of Science Citations: 4
Abstract

Graves' ophthalmopathy (GO) is one of the most severe clinical manifestations of Graves' disease (GD), and its treatment might involve high-dose glucocorticoid therapy. The higher incidence of GO among females, and the reported association between polymorphisms of estrogen receptor (ER) and GD susceptibility have led us to question the role of estrogen and its receptor in GO pathogenesis. We, thus, assessed estrogen receptor-alpha (ERA) gene expression in cultures of orbital fibroblasts from a patient with GO before (controls) and after treatment with 10 nM and 100 nM dexamethasone (DEX). Orbital fibroblasts showed ERA gene expression. In the cells treated with 10 nM and 100 nM DEX, ERA gene expression was, respectively, 85% higher and 74% lower, than in the control group. We concluded that ERA gene expression is found in the orbital fibroblasts of patient with GO, which may be affected by glucocorticoids in a dose-related manner. (AU)

FAPESP's process: 11/18464-8 - Gene expression of different hormone receptors in orbital fibroblasts, undergo adipocytic differentiation in patients with Graves' ophthalmopathy
Grantee:Sarah Santiloni Cury
Support type: Scholarships in Brazil - Scientific Initiation